We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
+10.48%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$5.44B
AUM Growth
+$720M
(+15%)
Cap. Flow
+$270M
Cap. Flow
% of AUM
4.96%
Top 10 Holdings %
Top 10 Hldgs %
32.29%
Holding
1,278
New
251
Increased
791
Reduced
201
Closed
31
Avg Time Held
3.1
quarters
Top 10 Avg Time Held
3.4
quarters
Top 20 Avg Time Held
3.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$17.4M |
| 2 |
Caterpillar
CAT
|
+$11.3M |
| 3 |
PNC Financial Services
PNC
|
+$10.7M |
| 4 |
Bank of America
BAC
|
+$9.3M |
| 5 |
Deere & Co
DE
|
+$8.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$28.7M |
| 2 |
Merck
MRK
|
+$24.3M |
| 3 |
Procter & Gamble
PG
|
+$15.6M |
| 4 |
Salesforce
CRM
|
+$11.5M |
| 5 |
GE Aerospace
GE
|
+$9.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.93% |
| 2 | Consumer Discretionary | 14.45% |
| 3 | Financials | 11.41% |
| 4 | Healthcare | 11.4% |
| 5 | Communication Services | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1226
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $64K | ﹤0.01% |
+179
| New | +$63.9K |
2021 Q2
0 quarters
|
|
1227
Definium Therapeutics
DFTX
$4.74B
| $61K | ﹤0.01% |
+1,175
| New | +$61.7K |
2021 Q2
0 quarters
|
|
1228
Agenus
AGEN
$339M
| $59K | ﹤0.01% |
+550
| New | +$41.2K |
2021 Q2
0 quarters
|
|
1229
Globalstar
GSAT
$10.8B
| $59K | ﹤0.01% |
+2,217
| New | +$43.5K |
2021 Q2
0 quarters
|
|
|
ENDP
1230
DELISTED
Endo International plc
ENDP
| $59K | ﹤0.01% |
+12,510
| New | +$71.7K |
2021 Q2
0 quarters
|
|
1231
Diversified Healthcare Trust
DHC
$1.85B
| $53K | ﹤0.01% |
+12,758
| New | +$52.7K |
2021 Q2
0 quarters
|
|
1232
Clear Channel Outdoor Holdings
CCO
$1.23B
| $52K | ﹤0.01% |
+19,884
| New | +$47.7K |
2021 Q2
0 quarters
|
|
1233
Invesco Mortgage Capital
IVR
$615M
| $51K | ﹤0.01% |
+1,311
| New | +$49.7K |
2021 Q2
0 quarters
|
|
1234
DELISTED
Asensus Surgical, Inc.
ASXC
| $41K | ﹤0.01% |
+12,814
| New | +$32K |
2021 Q2
0 quarters
|
|
1235
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $34K | ﹤0.01% |
+340
| New | +$33.1K |
2021 Q2
0 quarters
|
|
1236
VistaGen Therapeutics
VTGN
$10M
| $33K | ﹤0.01% |
+349
| New | +$25.9K |
2021 Q2
0 quarters
|
|
1237
Alaunos Therapeutics
TCRT
$2.35M
| $29K | ﹤0.01% |
+74
| New | +$34.5K |
2021 Q2
0 quarters
|
|
1238
Uranium Energy
UEC
$4.4B
| $29K | ﹤0.01% |
+11,055
| New | +$33.3K |
2021 Q2
0 quarters
|
|
1239
Kartoon Studios
TOON
$34.6M
| $28K | ﹤0.01% |
+1,546
| New | +$27K |
2021 Q2
0 quarters
|
|
|
EMWP
1240
DELISTED
Eros Media World PLC
EMWP
| $27K | ﹤0.01% |
+874
| New | +$23.9K |
2021 Q2
0 quarters
|
|
1241
Geron
GERN
$784M
| $23K | ﹤0.01% |
+16,429
| New | +$23.9K |
2021 Q2
0 quarters
|
|
1242
TherapeuticsMD
TXMD
$23.7M
| $23K | ﹤0.01% |
+380
| New | +$23K |
2021 Q2
0 quarters
|
|
1243
Tonix Pharmaceuticals
TNXP
$122M
| – | – |
0
| – | – |
2021 Q2
0 quarters
|
|
1244
DELISTED
DURECT Corp
DRRX
| $18K | ﹤0.01% |
+1,083
| New | +$18.9K |
2021 Q2
0 quarters
|
|
|
AMPE
1245
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $17K | ﹤0.01% |
+35
| New | +$18.8K |
2021 Q2
0 quarters
|
|
1246
iBio
IBIO
$57.3M
| $15K | ﹤0.01% |
+20
| New | +$14.6K |
2021 Q2
0 quarters
|
|
|
NMTR
1247
DELISTED
9 Meters Biopharma
NMTR
| $13K | ﹤0.01% |
+582
| New | +$14.3K |
2021 Q2
0 quarters
|
|
1248
Acadia Pharmaceuticals
ACAD
$3.37B
| – | – |
-11,827
| Closed | -$305K | – |
|
1249
DELISTED
Avanos Medical
AVNS
| – | – |
-5,307
| Closed | -$232K | – |
|
1250
Bath & Body Works
BBWI
$3.48B
| – | – |
-12,271
| Closed | -$614K | – |
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q2 2021 Portfolio in Review
As of Q2 2021, Xponance held 1,278 positions worth $5.44B, up 15% from $4.72B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Xponance deployed $270M of net new capital in Q2 2021, opening 251 new positions and adding to 791 existing holdings. Its largest new stake was Blackstone: 79,520 shares worth $7.72M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was UnitedHealth, an estimated $28.7M trimmed.
- Xponance's largest Q2 2021 buy was Blackstone: 79,520 shares worth $7.72M.
- Xponance added most to Home Depot in Q2 2021, an estimated $17.4M increase.
- Xponance's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $28.7M.
- Xponance fully exited GE Aerospace in Q2 2021, selling an estimated $9.87M.
- Xponance's ten largest holdings make up 32% of its $5.44B portfolio in Q2 2021.
- Xponance opened 251 new positions and closed 31 in Q2 2021.
- Xponance's portfolio value rose 15% quarter-over-quarter to $5.44B.
Based on Xponance's 13F filing for Q2 2021, filed 12 Aug 2021.